MedCity News June 21, 2022
Frank Vinluan

Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to help people live longer.

Human Longevity, Inc., (HLI), a company aiming to use genomic insights to help people live longer, has found a way to extend its corporate life. The firm has reached a merger deal that will take the company public and infuse it with $345 million to bring its life-extending approach to more users in the U.S. and around the world.

San Diego-based...

Today's Sponsors

pCare
Institute for Healthcare Improvement
Crossover Health

Today's Sponsors

ZeOmega
Holon

Today's Sponsor

Premier

 
Topics: Investments, Mergers & Acquisitions / JV, Pharma / Biotech, Precision Medicine, Trends
4 physician practice deals that are shaping industry
UnitedHealth Group’s Optum Closes $13 Billion Change Healthcare Deal
Done deal: UnitedHealth completes $13B Change Healthcare buy
Optum, Change Healthcare complete $7.8B merger
AstraZeneca to acquire gene editing biotech LogicBio